Join to access to all OVN content. Join for Free
First person profile: Supriya G. Mohile, MD, MS: A respected geriatric oncologist, Dr. Mohile has conducted innovative research on improving care for older patients with cancer
Supriya G. Mohile geriatric oncologist

First person profile: Supriya G. Mohile, MD, MS: A respected geriatric oncologist, Dr. Mohile has conducted innovative research on improving care for older patients with cancer


Share This Article


Summary

 

  • Ms. Canin and Dr. Mohile collaborated to involve patients and caregivers in geriatric oncology studies, forming the SCOREboard advisory group.

  • Dr. Mohile received a $2 million grant to create infrastructure for cancer and aging studies, and she is recognized as a leader in geriatric oncology.

  • Her research integrates geriatrics into oncology, addressing the growing older cancer patient population, with a focus on community oncology practices.

  • Geriatric assessments (GAs) are used to improve outcomes for older cancer patients, identifying those at high risk for chemotherapy toxicity.

  • Dr. Mohile, Dr. Dale, and Dr. Hurria developed ASCO guidelines recommending GAs for chemotherapy decision-making in older patients.

  • Dr. Mohile balances her professional life with personal interests, including dining, Zumba, and reading romance novels.

 

Beverly Canin, an 85-year-old breast cancer survivor and patient advocate, remembers when she first met Supriya G. Mohile, MD, MS, a geriatric oncologist and the Philip and Marilyn Wehrheim Professor in the division of hematology/oncology at the University of Rochester Medical Center (URMC) in New York. In 2011, Ms. Canin, who had begun attending annual meetings of the American Society of Clinical Oncology (ASCO), went to a session that focused on cancer in the “oldest old” adults, namely those aged ≥85 years. Dr. Mohile was part of that panel, along with her colleagues, William Dale, MD, PhD, who is currently the chair of supportive care medicine at the City of Hope cancer center in Duarte, California, and the late Arti Hurria, MD, who had served as director of the City of Hope's Center for Cancer and Aging...

Click for Source Download PDF version
Supriya G. Mohile, geriatric oncologist

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
OVN Avatar S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale

Article
Sponsorship of oncology clinical trials in the United States according to age of eligibility
OVN Avatar Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois

Sponsorship of oncology clinical trials in the United States according to age of eligibility

Article
Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?
OVN Avatar Karen Geary

Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Article
Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
OVN Avatar J. Remon, R. García-Campelo, E. de Álava, R. Vera, J. L. Rodríguez-Peralto, Á. Rodríguez-Lescure, B. Bellosillo, P. Garrido, F. Rojo & R. Álvarez-Alegret

Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Article
Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer
OVN Avatar Stefanie Broes, Robbe Saesen, Denis Lacombe, Isabelle Huys

Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer

Explore OVN